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TCT-124
Distal Embolization of Hydrophilic Coating Material from Coronary Guide
Wires after Percutaneous Coronary Interventions
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Jan Piek2, Jan G. Tijssen1, Karel T. Koch1, Joanna J. Wykrzykowska4,
Robbert J. de Winter1, Allard C. van der Wal2
1Academic Medical Center - University of Amsterdam, Amsterdam, Netherlands,
2Academic Medical Center, Amsterdam, Netherlands, 3University Medical Center
Utrecht, Utrecht, Netherlands, 4Academic Medical Center - University of Amsterdam,
Amsterdam, MI
Background: Coronary guide wires are indispensable during percutaneous coronary
interventions (PCI). Nowadays, most have hydrophilic coatings to improve their
performance. Recent reports however have raised concerns about detachment and
embolization of these coatings.
Methods: We have retrospectively reviewed histological myocardial samples, ob-
tained during autopsies (period 2009- 2013), from all patients with a history of PCI
(n¼40). Furthermore, we have reviewed 205 thrombus specimen, obtained with
thrombus aspiration during primary PCI (period 2005-2009). Finally, we have
examined the histopathological appearance of hydrophilic coatings ‘ex-vivo’ by
embedding this coating in placenta specimen and cut and stain it in exactly the same
manner as the myocardium and thrombus specimen.
Results: Foreign material was observed in the distal myocardium in 4 patients (10%)
with a history of PCI (see ﬁgure). Furthermore, from the 205 reviewed thrombus
specimen, foreign material was observed within the thrombus in 45% of the cases.
Finally, the histopathological appearance of the hydrophilic coating ‘ex-vivo’ was
identical to the foreign material found ‘in-vivo’.
Conclusions:We observed distal embolization of hydrophilic coating material in 10%
of the patients with a history of PCI and detachment from the guide wire during 45%
of the thrombus aspirations. These ﬁndings suggest that detachment and distal
embolization of hydrophilic coating material from coronary guide wires occurs more
often than the sparse literature on this topic suggests.TCT-125
Stent Loss Associated With Use Of The GuideLiner Catheter In Percutaneous
Coronary Interventions
Thomas M. Waterbury1, Paul Sorajja2, Rajiv Gulati3
1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic,
Rochester, United States
Background: In patients with complex coronary anatomy such as chronic total oc-
clusion or tortuous vessels, stent delivery can be challenging and result in procedural
failure. The GuideLiner catheter is a coaxial guide extension system designed to
enhance deep vessel engagement and device delivery for difﬁcult coronary
interventions. This study was designed to investigate the incidence of stent loss andB38 JACC Vol 64/11/Suppl Bother complications associated with use of the GuideLiner “mother-and-child” cath-
eter system during percutaneous coronary intervention (PCI).
Methods: This single center, retrospective review was conducted using our in-
stitution’s percutaneous coronary intervention database involving consecutive cases
between February 2010 and July 2011. Data was extracted from cases in which the
GuideLiner system was utilized to facilitate device delivery. Procedural reports and
cine angiography were reviewed.
Results: A series of 104 eligible cases using the GuideLiner system during PCI were
identiﬁed. The mean preprocedural stenosis of culprit lesions based on visual angio-
graphic estimation was 84.8% ( 12.3). Procedural success resulting in stent place-
ment with the GuideLiner catheter was achieved in 72.1% of cases (75/104). The
incidence of stent loss associated with GuideLiner use was found to be 5.8% (6/104).
Vessel dissection attributed to GuideLiner intubation of target vessels occurred in
12.5% of cases (13/104).
Conclusions: To date, this is the largest single review of cases involving the
GuideLiner catheter extension system during PCI. Our results further validate the
utility of the GuideLiner system in the setting of high lesion complexity and vessel
tortuosity. Complications of device application included stent disruption and loss,
vessel dissection, and ventricular arrhythmia.
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Thrombin Clot Injection for the Treatment of Coronary Wire Perforation
Yuta Imai1, Yasuhiro Tarutani1, Fumitaka Hosaka1, Kazuya Shinji1,
Tomohide Yoshino1, Masanori Teramura1, Motohiko Kakuno1
1Okamura Memorial Hospital, Shizuoka, Japan
Background: Coronary perforation (CP) is a rare but potentially fatal complication of
percutaneous coronary intervention (PCI). Coronary wire perforation (WP) has been
the most frequent cause of CP in the current era. Most of WPs can be treated with
endovascular means. The embolization therapy is needed when the conservative
approach such as prolonged balloon inﬂation fails. We have much experience of
thrombin clot injection (TCI) for the treatment of WP.
Methods: From June 2007 to September 2013, CPs were identiﬁed in 73 (1.44%) of
5077 consecutive PCIs at our institution. WP was the most common cause of CP
occurring in 53 of 73 cases (72.6%). 25 of 53 WPs (47.2%) were treated using
transmicrocatheter injection of “thrombin clot” made by mixing thrombin solution and
autologous blood.
Results: As treatment for WP, reversal of anticoagulation (n¼38; 71.7%), negative
pressure in the microcatheter (n¼5; 9.4%), prolonged balloon inﬂation (n¼12; 22.6%),
TCI (n¼25; 47.2%) and microcoil embolization (n¼4; 7.5%) were used in different
combinations. 6WPs were treated with only observation (11.3%). In hospital death was
caused by acute myocardial infarction in one patient of the observation group. Cardiac
tamponade occurred in three patients and two of these had a delayed presentation. In the
all cases treated with TCI, we successfully stopped bleeding without requiring further
procedures and cardiac tamponade. We failed to stop bleeding in one of four cases
treated with microcoils and the bleeding could be ﬁnally stopped by TCI. Clinical
outcomes of TCI forWP are shown in the table. Hemostasis was achievedmore securely
and rapidly with TCI than with the other means. However, serious thrombosis leading to
myocardial infarction occurred in two patients with TCI.j September 13–17, 2014 jThrombin clot injectionTCT Abstracts/ComOther meansplications - CP-valueNumber of patient 25 28Age 73.4  10.9 72  7.6 NS
CTO 10 (40%) 13 (46.4%) NSEllis II 9 (36%) 3 (10.7%) <0.05Use of protamine 18 (72%) 26 (92.9%) 0.067Success of hemostasis 25 (100%) 15 (53.6%) <0.001Duration of procedure (min SD) 15.3  14.4 49.5  37.6 <0.001
Delayed tamponade 0 (0%) 2 (8.7%) NSProcedure-related MI 3 (12%) 0 (0%) 0.098Thrombosis 2 (8%) 0 (0%) NSConclusions: TCI for WP is simple, inexpensive, readily available and effective but it
may increase the risk of thrombosis.
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www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMBackground: The frequency and prognostic impact of bleeding after hospital
discharge for PCI has not been well studied. We sought to identify the incidence,
predictors and prognostic impact of post-discharge bleeding (PDB) after percutaneous
coronary intervention (PCI) at 2 years.
Methods: ADAPT-DES was a prospective, multicenter registry of patients success-
fully treated with one or more drug-eluting stents. Patients were stratiﬁed and 2-year
outcomes according to the occurrence of PDB.
Results: Among 8,582 patients who underwent PCI in ADAPT-DES, PDB occurred in
610/8,577 hospital survivors (7.1%) at median time of 210 [17, 453] days after the index
procedure. Gastrointestinal bleeding (n¼208; 34.1%) was the most frequent type of PDB.
Independent predictors of PDB were in-hospital bleeding (HR [95%CI] ¼ 12.27
[9.92,15.16], P< 0.0001), warfarin use at discharge (HR [95%CI] ¼ 1.60 [1.23, 2.09],
P¼0.0005), presence of coronary calciﬁcation (HR [95%CI] ¼ 1.27 [1.06, 1.51],
P¼0.008), lower creatinine clearance (HR [95%CI] ¼ 1.04 [1.02, 1.07], P¼0.002), pe-
ripheral arterial disease (HR [95%CI]¼ 1.40 [1.13, 1.75], P¼0.003), andVerifyNowPRU
208 (HR [95%CI] ¼ 1.20 [1.01, 1.43], P¼0.03). PDB was strongly associated with 2-
year adverse outcomes (Table). By multivariable analysis, including the occurrence of
myocardial infarctionpost-discharge as a time-dependent co-variable, PDBwas a powerful
independent predictor of 2-year mortality (HR [95%CI]¼ 3.91 [2.90, 5.27], P< 0.0001).
Conclusions: PDB after DES occurs within 2 years in w1 in 14 patients, and is
strongly predictive of long-term mortality.Table 2. Two-year Outcomes According to Post-discharge Bleeding
Post-discharge Bleeding
(n¼610)
No Post-discharge Bleeding
(n¼7967) P-value
Death 70 (11.8) 241 (3.2) <0.0001
Cardiovascular 39 (6.8) 154 (2.1) <0.0001
Non-cardiovascular 31 (5.3) 87 (1.2) <0.0001
Myocardial infarction 60 (10.7) 209 (2.8) <0.0001
Q-wave 8 (1.4) 38 (0.5) 0.006
Non Q-wave 52 (9.3) 176 (2.4) <0.0001
Deﬁnite /probable ST 8 (1.4) 76 (1.0) 0.38
Major adverse cardiac
events
124 (21.5) 645 (8.5) <0.0001
Target vessel failure 195 (32.6) 968 (12.8) <0.0001
Data presented as n (%); major adverse cardiac events is a composite of cardiac death,
myocardial infarction or target lesion revascularization; Target vessel failure is a composite of
death, myocardial infarction and target vessel revascularization; ST¼stent thrombosis
Table 1. Freedom from 1-year MACE: ORBIT II Males vs Females
Males Females p-value
Freedom from MACE (%) 83.5 83.8 0.88
Freedom from cardiac death (%) 96.1 98.7 0.15
Freedom from MI (%) 89.9 91.1 0.67
Freedom from Q-wave MI (%) 99.0 99.3 0.67
Freedom from Non-Q-wave MI (%) 90.9 91.7 0.77
Freedom from TVR/TLR (%) 94.6 93.3 0.61
MACE: major adverse cardiac events; MI: myocardial infarction; TVR: target vessel revascu-
larization; TLR: target lesion revascularization
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TCT-128
Diamondback 360 Coronary Orbital Atherectomy System for Treating De Novo,
Severely Calciﬁed Coronary Lesions in Elderly Patients: 1-Year Results from the
ORBIT II Trial
Arthur Lee1, Jeffrey Chambers2
1Cardiac & Vascular Institute, Gainesville, United States, 2MHVI Minneapolis, MN,
Minneapolis, United States
Background: Percutaneous coronary intervention (PCI) in elderly patients is associated
with higher rates of complications and worse short term prognosis. This may be due to
increased co-morbidities including renal disease, tortuous vascular anatomy, and
calciﬁed arteries. For these reasons, elderly patients are excluded from many clinical
trials, leading to a paucity of evidence to determine optimal therapy for these patients. In
this analysis, we evaluate the 1-year outcomes of elderly patients in the ORBIT II Trial.
Methods: ORBIT II (443 patients, 49 US sites) is the ﬁrst prospective trial to
exclusively study patients with severely calciﬁed coronary lesions. The Diamondback
360 Coronary Orbital Atherectomy System (OAS) (Cardiovascular Systems, Inc.,
St. Paul, MN) was used to modify and prepare lesions prior to stent placement. The
major adverse cardiac event (MACE) rate was examined at one-year in patients
75 years of age (N¼174) and < 75 years of age (N¼269).
Results: Patients 75 years of age were more likely to be former smokers, have lower
eGFR at baseline, lower body mass index at baseline, as well as higher prevalence of
history of hypertension and stroke. The total length of calcium in patients 75 years
of age was longer compared to patients < 75 years of age (30.6  1.3 mm vs. 27.1 
1.0 mm, p¼0.01). As estimated by Kaplan Meier at 1-year, patients 75 years of ageJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Atand patients < 75 years of age had similar high freedom from MACE (82.7% vs.
84.2%, p¼0.67), myocardial infarction (MI) (89.1% vs. 91.1%, p¼0.50), non-Q-wave
MI (89.7% vs. 92.2%, p¼0.37), Q-wave MI (99.4% vs. 98.9%, p¼0.56), target vessel
revascularization/target lesion revascularization (TVR/TLR) (94.1% vs. 94.2%,
p¼0.97) and cardiac death (97.1% vs. 96.9%, p¼0.93).
Conclusions: Despite more complex lesions elderly patients with severely calciﬁed
coronary arteries had similar outcomes compared to younger patients when treated
with the Diamondback 360 Coronary OAS to facilitate stent delivery.
TCT-129
Gender Differences in 1-Year Outcomes in Patients Treated with the
Diamondback 360 Coronary Orbital Atherectomy System: Results from the
ORBIT II Trial
Christopher Kim1, Jeffrey Chambers2
1Utah Cardiology, PC, Layton, UT, 2MHVI Minneapolis, MN, Minneapolis,
United States
Background: A negative correlation between female gender and some in-hospital
adverse events after percutaneous coronary intervention (PCI) has been reported. In
this analysis, we evaluate the 1-year outcomes of male and female patients in the
ORBIT II Trial.
Methods: The prospective ORBIT II Trial enrolled 443 patients at 49 sites in the U.S.
and patients were treated with the Diamondback 360 Coronary Orbital Atherectomy
System (OAS) (Cardiovascular Systems, Inc., St. Paul, MN) to prepare de novo,
severely calciﬁed coronary lesions for stent placement. In this analysis, the 1-year
major adverse cardiac event (MACE) rate, deﬁned as myocardial infarction (MI),
cardiac death, and target vessel revascularization (TVR) was evaluated in male
(N¼286) and female (N¼157) ORBIT II patients as estimated by Kaplan-Meier.
Results: At baseline compared to males, females were older (73.3  0.8 vs 70.4 
0.6, p¼0.001) and had lower mean eGFR (71.3  2.1 vs 78.2  1.5, p¼0.002). Males
had a higher rate of previous coronary artery bypass graft (18.2% vs 8.3%, p¼0.005).
The rate of successful stent delivery (96.8% vs 99.4%, p¼0.11) and < 50% residual
stenosis (98.2% vs 99.4%, p¼0.43) was similar in males and females, respectively. As
shown in Table 1, both males and females had high freedom from 1-year MACE.Conclusions: Preparation of severely calciﬁed coronary lesions with the Diamond-
back 360 Coronary OAS to facilitate stent deployment results in high rates of freedom
from 1-year MACE, irrespective of gender.
TCT-130
FACTORS ASSOCIATED WITH LONG-TERM CARDIOVASCULAR
EVENTS FOLLOWING ROTATIONAL ATHERECTOMY
Christos Eftychiou1, David Barmby1, Simon J. Wilson2, Salahaddin Ubaid3,
Andrew J. Markwick3, James C. Spratt4, Mark Gunning3, John Greenwood1
1Leeds General Inﬁrmary, Leeds, United Kingdom, 2Royal Inﬁrmary of Edinburgh,
Edinburgh, United Kingdom, 3University Hospital of North Staffordshire, Stoke-on-
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Background: Rotational atherectomy (RA) is an effective way to mechanically
debulk heavily calciﬁed lesions before stenting. We sought to identify procedural
factors associated with long term cardiovascular outcome.
Methods: Retrospective evaluation of all patients who underwent RA and PCI in three
large UK tertiary cardiac centres (Leeds General Inﬁrmary, Royal Inﬁrmary of
Edinburgh and University Hospital of North Staffordshire) from 14/3/2005 to
18/1/2013. MACE was deﬁned as cardiac death, MI and TVR.
Results: 518 patients (mean age 71.5+/-9.3yrs) had RA with mean follow-up 27.6+/-
17.3 months. 68.3% were male, 28.7% had diabetes mellitus (DM) and 34.6% were
treated because of ACS. 974 stents were implanted in 97.3% of the cases
(75.9% DES). 30.7% performed transradially and 32.7% used a GP IIb/IIIa inhibitor.
Maximum burr size was 1.75mm in 85.5% of patients; mean SYNTAX score
19.5+/-11.6. Procedural complications occurred in 6.3% patients and vascular com-
plications in 2.1%. Outcomes in the follow up period were: MACE 18.7%, all-cause
death 13.7%, cardiac death 6.6%, MI 11.2%, TVR 7.5%, deﬁnite stent thrombosis
(ST) 1.2% and stroke 2.9%. Patients with intermediate and high syntax scores (>22
and >32) were more likely to have an MI, ST, MACE, cardiac death or death from
any cause (table 1). Patients with a syntax score >32 were more likely to have aherectomy and Plaque Modiﬁcation B39
